FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines

FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines

Updated warnings for eszopiclone, zaleplon and zolpidem

The U.S. Food and Drug Administration today announced the agency is requiring a new boxed warning – the agency’s most prominent warning – on certain prescription insomnia drugs to better ensure patients and their health care professionals have the information they need when considering use of these medicines. The boxed warning follows several reports of rare, but serious injuries and deaths resulting from various complex sleep behaviors after taking these medicines. These complex sleep behaviors...

Read More